1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends

2015 Infectious Disease Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

  • June 2015
  • 1060 pages
  • Venture Planning Group
Report ID: 2162943

Summary

Table of Contents

Complete report $11,500.  DataPack  (test volumes, sales forecasts, supplier shares) $7,500.


2015 Infectious Disease Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests performed in hospitals, blood banks, commercial laboratories, physician offices, public health, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

 

Rationale


This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

  

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade.  Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.


Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.


Opportunities and Strategic Recommendations


- Emerging opportunities for new instrumentation,

  reagents kits, IT and other products with significant market

  appeal during the next five years.


- Design criteria for decentralized testing products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Infectious Diseases Analyzed in the Report


AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,

Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,

Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,

Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,

Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,

Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus,

Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis,

Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.


Market Segmentation Analysis


- Sales and market shares of major suppliers

  by individual test.


- Volume and sales forecasts for over 100 infectious disease

   assays by individual test and market segment:


Centralized Testing    

 

- Hospitals

- Commercial/Private Laboratories

- Blood Banks

- Public Health Laboratories


POC/Decentralized Testing


- Physician Offices/Group Practices   

- Emergency Rooms       

- Operating/Recovery Suites     

- ICUs/CCUs

- Cancer Clinics       

- Ambulatory Care Centers       

- Surgery Centers

- Nursing Homes

- Birth Centers


- Test volume estimates by method (molecular, serology/immunodiagnostics,

   culture/microscopy).


- Review of the market dynamics, trends,

  structure, size, growth and major suppliers.


Current and Emerging Products


- In-depth examination of over 100 major diseases,

  including their etiology, current diagnostic tests,

  vaccines, drugs and market needs.


- Review of major analyzers used for infectious disease

  testing, including their operating

  characteristics, features and selling prices.


Technology Review


- Assessment of molecular diagnostic, monoclonal antibody,

  immunoassay, and other technologies and their potential

  applications for infectious disease testing.


- Global listings of companies developing or

  marketing infectious disease diagnostic products

  by individual test.


Competitive Assessments


- Strategic assessments of major suppliers and

  emerging market entrants, including their sales, product

  portfolios, marketing tactics, collaborative

  arrangements and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - Affymetrix

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biomerieux

   - Bio-Rad

   - Cepheid      

   - Diamedix           

   - Diasorin

   - Eiken Chemical

   - Elitech Group

   - Enzo Biochem

   - Fujirebio

   - Grifols

   - Hologic/Gen-Probe

   - ID Biomedical/GSK

   - Kreatech/Leica

   - Lonza

   - Ortho-Clinical Diagnostics

   - Qiagen

   - Roche

   - Scienion

   - Sequenom

   - SeraCare

   - Siemens

   - Takara Bio

   - ThermoFisher

   - Wallac/PE

   - Wako


Contains 1,060 pages and 192 tables

“2015 Infectious Disease Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests performed in hospitals, blood banks, commercial laboratories, physician offices, public health, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28500
  • Industry report
  • March 2017
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

Tumor Markers 2021: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2017 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.